Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

This study has been terminated.
(Just Terminated for the end of the pandemia)
Sponsor:
Collaborators:
Hoffmann-La Roche
GlaxoSmithKline
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00799760
First received: November 28, 2008
Last updated: March 16, 2012
Last verified: November 2008